The differentially expressed circular ribonucleic acids of primary hepatic carcinoma following liver transplantation as new diagnostic biomarkers for primary hepatic carcinoma

Recent studies have shown that circular ribonucleic acids have differential expression in some diseases. This study compared the expression levels of five circular ribonucleic acids between patients of primary hepatic carcinoma following liver transplantation and healthy individuals for searching a new diagnostic biomarker about primary hepatic carcinoma. We chose differentially expressed targeted circular ribonucleic acids according to fold change ≥2.0 or ≤–2.0 between circular ribonucleic acids microarray of perioperative liver transplantation and normal controls. Then we used the Arraystar home-made micro-ribonucleic acid target prediction software based on TargetScan and miRanda to predict circular ribonucleic acid/micro-ribonucleic acid interactions. And we assess the expression levels of hsa_circ_100571, hsa_circ_400031, hsa_circ_102032, hsa_circ_103096, and hsa_circ_102347 in the peripheral blood of normal controls and liver transplantation patients before transplantation and on the first, third, and seventh days after transplantation by real-time quantitative polymerase chain reaction. We chose five circular ribonucleic acids, two of which have been correlated with micro-ribonucleic acid–related carcinoma recurrence after liver transplantation, hepatocellular carcinoma and analyzed their expression with 2–△△Ct method. The expression level of hsa_circ_100571 and hsa_circ_400031 on day 1 after liver transplantation was higher than pre-transplantation (p < 0.01), and these levels showed a declining trend on post-transplantation. The expression level of hsa_circ_102032 and hsa_circ_103096 on day 1 after liver transplantation was lower than pre-transplantation (p < 0.01) and decreased on post-transplantation. There were the significantly different expressions between the post-transplantation day 7 and normal control (p < 0.01). The expression level of hsa_circ_102347 on day 1 after liver transplantation was lower than pre-transplantation (p < 0.01). This expression showed a declining trend on post-transplantation, and the postoperative day 7 level was similar to normal control (p > 0.05). Five types of circular ribonucleic acid–related micro-ribonucleic acids had varying degrees of upregulation and downregulation between perioperative transplantation of primary hepatic carcinoma patients and normal controls; the hsa_circ_102347 is most likely to have association with primary hepatic carcinoma.

[1]  S. Finkelstein,et al.  Role of liver transplantation for hepatobiliary malignant disorders. , 2004, The Lancet. Oncology.

[2]  K. Majidzadeh-A,et al.  BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer , 2013, Medical Oncology.

[3]  J. Kjems,et al.  Natural RNA circles function as efficient microRNA sponges , 2013, Nature.

[4]  Shenmin Zhang,et al.  circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family , 2017, Oncogene.

[5]  T. Xia,et al.  Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance , 2013, Tumor Biology.

[6]  Junming Guo,et al.  Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association , 2013, Medical Oncology.

[7]  Phillip A. Sharp,et al.  A Circuitous Route to Noncoding RNA , 2013, Science.

[8]  Antai Wang,et al.  Exploration of Genome-Wide Circulating MicroRNA in Hepatocellular Carcinoma: MiR-483-5p as a Potential Biomarker , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[9]  A. Pasquinelli MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship , 2012, Nature Reviews Genetics.

[10]  Michael K. Slevin,et al.  Circular RNAs are abundant, conserved, and associated with ALU repeats. , 2013, RNA.

[11]  Lei Liu,et al.  Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. , 2016, Cancer biomarkers : section A of Disease markers.

[12]  N. Sharpless,et al.  Detecting and characterizing circular RNAs , 2014, Nature Biotechnology.

[13]  Shanshan Zhu,et al.  Circular intronic long noncoding RNAs. , 2013, Molecular cell.

[14]  Ming Liu,et al.  Circular RNA: a novel biomarker for progressive laryngeal cancer. , 2016, American journal of translational research.

[15]  Huajie Cai,et al.  cir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway , 2015, PloS one.

[16]  Xiaoyan Mo,et al.  Using circular RNA as a novel type of biomarker in the screening of gastric cancer. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[17]  R. Deng,et al.  Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: Hirsutanol A inhibits tumor growth through ROS production , 2013, Journal of Translational Medicine.

[18]  J. Im,et al.  Repression of α-synuclein expression and toxicity by microRNA-7 , 2009, Proceedings of the National Academy of Sciences.

[19]  Qingfa Wu,et al.  Homology-independent discovery of replicating pathogenic circular RNAs by deep sequencing and a new computational algorithm , 2012, Proceedings of the National Academy of Sciences.

[20]  Sebastian D. Mackowiak,et al.  Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.

[21]  Zhong Liu,et al.  Long non-coding RNA expression profile in human gastric cancer and its clinical significances , 2013, Journal of Translational Medicine.

[22]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[23]  Jun-Wei FanJun miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver , 2012 .